Home Headlines Curevac and Novavax start phase III COVID-19 clinical trials in Mexico

Curevac and Novavax start phase III COVID-19 clinical trials in Mexico

by Yucatan Times
0 comment

MEXICO CITY (Latinus) – Mexico’s foreign minister Marcelo Ebrard said on Friday that CureVac and Novavax have begun their phase III clinical trials in Mexico for a COVID-19 vaccine.

“China’s CanSino Biologics Inc is due to present the results of its phase III trial”, Ebrard also said.

In the case of Novavax , the Ministry of Foreign Relations ( SRE ) reported on December 28 that Mexico was going to participate in phase 3 clinical trials of its vaccine against Covid-19 during January.

“The study recruited two thousand volunteers in seven sites in the Mexican Republic, which will make it possible to collect data on the efficacy of the vaccine in our population,” the Foreign Ministry said in a statement.

You may also like

Leave a Comment

Our Company

Lorem ipsum dolor sit amet, consect etur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis.

Newsletter

Laest News

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?
-
00:00
00:00
Update Required Flash plugin
-
00:00
00:00